Joseph Oliveto Healthcare News

This is selected healthcare news for Joseph Oliveto, which is filed under People. There are 79 news items for this page.

Please provide a valid email address.

Selected Headlines

Date Headline (link) Source
8/10/2022 Milestone Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Clinical and Corporate Update
... RAPID trial, we now focus on the final stages of data cleaning and analysis and look forward to reporting top line data in the middle of the second half of this year," said Joseph Oliveto , President and Chief Executive Officer of Milestone Pharmaceuticals. Recent Updates Achieved Required Number of PSVT ...
PR Newswire
5/17/2022 Milestone Pharmaceuticals to Present at the H.C. Wainwright Global Investment Conference
MONTREAL and CHARLOTTE, N.C. , May 17, Milestone Pharmaceuticals Inc. (Nasdaq: MIST ), a biopharmaceutical company focused on the development and commercialization of innovative cardiovascular medicines, today announced that Joseph Oliveto , President and Chief Executive Officer, will participate in a fireside chat at the H.C. Wainwright Global Investment Conference being held on ...
PR Newswire
5/12/2022 Milestone Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Clinical and Corporate Update
... provided a clinical and corporate update. "The beginning of 2022 has been a productive time for Milestone, marked by continued progress advancing our lead Phase 3 program, etripamil, for patients with PSVT," said Joseph Oliveto , President and Chief Executive Officer of Milestone Pharmaceuticals. "Of note, we were particularly excited by ...
PR Newswire
3/24/2022 Milestone Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Clinical and Corporate Update PR Newswire
3/24/2022 Milestone Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Clinical and Corporate Update Yahoo News
2/16/2022 Milestone Pharmaceuticals Announces Appointment of David Bharucha, M.D., Ph.D., as Chief Medical Officer PR Newswire
9/7/2021 Milestone Pharmaceuticals to Present at the H.C. Wainwright 23rd Annual Global Investment Conference PR Newswire
8/11/2021 Milestone Pharmaceuticals Reports Second Quarter 2021 Financial Results and Provides Clinical and Corporate Update PR Newswire
3/30/2021 Milestone Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Clinical and Corporate Update Yahoo News
3/29/2021 Milestone Pharmaceuticals Announces First Patient Enrolled in the ReVeRA Study, its Phase 2 Trial of Etripamil in Atrial Fibrillation and Rapid Ventricular Rate PR Newswire
3/29/2021 Milestone Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Clinical and Corporate Update Business Insider
9/22/2020 Milestone Pharmaceuticals Strengthens Board of Directors with Two New Appointments PR Newswire
9/22/2020 Milestone Pharmaceuticals Strengthens Board of Directors with Two New Appointments tncontentexchange.com
9/22/2020 Milestone Pharmaceuticals Strengthens Board of Directors with Two New Appointments tncontentexchange.com
9/22/2020 Milestone Pharmaceuticals Strengthens Board of Directors with Two New Appointments BioSpace
9/22/2020 Milestone Pharmaceuticals Strengthens Board of Directors with Two New Appointments PR Newswire
9/22/2020 Milestone Pharmaceuticals Strengthens Board of Directors with Two New Appointments gurufocus.com
9/8/2020 Milestone Pharmaceuticals to Present at Upcoming Investor Conferences PR Newswire
8/12/2020 Milestone Pharmaceuticals Reports Second Quarter 2020 Financial Results and Provides Clinical and Corporate Update PR Newswire
8/12/2020 Milestone Pharmaceuticals Reports Second Quarter 2020 Financial Results and Provides Clinical and Corporate Update BioSpace
8/12/2020 Milestone Pharmaceuticals Reports Second Quarter 2020 Financial Results and Provides Clinical and Corporate Update tncontentexchange.com
8/12/2020 Milestone Pharmaceuticals Reports Second Quarter 2020 Financial Results and Provides Clinical and Corporate Update tncontentexchange.com
8/8/2020 Milestone Pharmaceuticals Inc. [MIST] Analysis: Why MIST Stock Is Skyrocketing Today mzpnews.com
8/6/2020 Milestone Pharmaceuticals to Present at the Canaccord Genuity 40th Annual Growth Conference gurufocus.com
7/23/2020 Milestone Pharmaceuticals Announces Regulatory Guidance and Updated Clinical Development Plan for Etripamil in PSVT PR Newswire